Get startedLog in
    Picture of Lineage Cell Therapeutics logo

    LCTX — Lineage Cell Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Lineage Provides Positive Update On Phase I/Iia Clinical Study Of Opregen®

    Picture of Lineage Cell Therapeutics logoLineage Cell Therapeutics
    06/02/2020 13:19
    Feb 6 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE PROVIDES POSITIVE UPDATE ON PHASE I/IIA CLINICAL
STUDY
OF OPREGEN® FOR THE TREATMENT OF DRY AGE-RELATED MACULAR
DEGENERATION

Source text for Eikon:  ID:nBw3hdWjja 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Lineage Cell Therapeutics

    See all news